Royal DSM N.V.
ISIN: NL0000009827 | Ticker: DSM | LEI: 724500SNT1MK246AHP04
Country: Netherlands
Koninklijke DSM N.V. operates as a life and materials sciences company. From century-old roots as the Dutch State Mines, DSM has evolved into a purpose-led science-based global company specializing in solutions for human and animal health and nutrition. Our purpose is to create brighter lives for all – which is why we’re proud that our name has assumed a new meaning among our people in recent years: Doing Something Meaningful. DSM’s business groups are clustered in coherent product and market combinations: Animal Nutrition & Health, Human Nutrition, Care & Health, Food & Beverage, and Materials.
Year founded1902
Served areaWorldwide
HeadquartersHet Overloon 1, 6411 Heerlen – Netherlands
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 14,346,000,000.00 | 16,020,000,000.00 | 17,403,000,000.00 |
| Noncurrent Assets | N/A | 8,926,000,000.00 | 9,890,000,000.00 | 9,275,000,000.00 |
| Property Plant And Equipment | N/A | 3,775,000,000.00 | 3,964,000,000.00 | 3,576,000,000.00 |
| Investment Accounted For Using Equity Method | N/A | 93,000,000.00 | 64,000,000.00 | 61,000,000.00 |
| Deferred Tax Assets | N/A | 240,000,000.00 | 203,000,000.00 | 95,000,000.00 |
| Other Noncurrent Financial Assets | N/A | 315,000,000.00 | 227,000,000.00 | 295,000,000.00 |
| Noncurrent Recognised Assets Defined Benefit Plan | N/A | 2,000,000.00 | 75,000,000.00 | 19,000,000.00 |
| Noncurrent Derivative Financial Assets | N/A | 61,000,000.00 | 48,000,000.00 | 82,000,000.00 |
| Current Assets | N/A | 5,420,000,000.00 | 6,130,000,000.00 | 8,128,000,000.00 |
| Inventories | N/A | 1,879,000,000.00 | 2,297,000,000.00 | 2,339,000,000.00 |
| Current Trade Receivables | N/A | 1,391,000,000.00 | 1,604,000,000.00 | 1,508,000,000.00 |
| Other Current Receivables | N/A | 60,000,000.00 | 32,000,000.00 | 78,000,000.00 |
| Current Tax Assets Current | N/A | 32,000,000.00 | 61,000,000.00 | 36,000,000.00 |
| Cash and cash equivalents | N/A | 871,000,000.00 | 1,561,000,000.00 | 2,755,000,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | 1,096,000,000.00 | 56,000,000.00 | 1,245,000,000.00 |
| Current Derivative Financial Assets | N/A | 48,000,000.00 | 30,000,000.00 | 42,000,000.00 |
| Current Investments | N/A | 43,000,000.00 | 489,000,000.00 | 125,000,000.00 |
| Equity And Liabilities | N/A | 14,346,000,000.00 | 16,020,000,000.00 | 17,403,000,000.00 |
| Equity | 7,835,000,000.00 | 7,487,000,000.00 | 9,397,000,000.00 | 10,845,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 7,399,000,000.00 | 9,318,000,000.00 | 10,743,000,000.00 |
| Noncontrolling Interests | N/A | 88,000,000.00 | 79,000,000.00 | 102,000,000.00 |
| Noncurrent Liabilities | N/A | 4,616,000,000.00 | 4,193,000,000.00 | 3,978,000,000.00 |
| Noncurrent Provisions | N/A | 123,000,000.00 | 96,000,000.00 | 74,000,000.00 |
| Deferred Tax Liabilities | N/A | 431,000,000.00 | 490,000,000.00 | 476,000,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 414,000,000.00 | 323,000,000.00 | 241,000,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | 1,000,000.00 | 9,000,000.00 | 4,000,000.00 |
| Other Noncurrent Liabilities | N/A | 163,000,000.00 | 280,000,000.00 | 205,000,000.00 |
| Longterm Borrowings | N/A | 3,484,000,000.00 | 2,995,000,000.00 | 2,978,000,000.00 |
| Current Liabilities | N/A | 2,243,000,000.00 | 2,430,000,000.00 | 2,580,000,000.00 |
| Current Provisions | N/A | 61,000,000.00 | 68,000,000.00 | 50,000,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 1,218,000,000.00 | 1,571,000,000.00 | 1,415,000,000.00 |
| Current Tax Liabilities Current | N/A | 45,000,000.00 | 77,000,000.00 | 64,000,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 254,000,000.00 | 10,000,000.00 | 430,000,000.00 |
| Current Recognised Liabilities Defined Benefit Plan | N/A | 42,000,000.00 | 21,000,000.00 | 22,000,000.00 |
| Current Derivative Financial Liabilities | N/A | 13,000,000.00 | 40,000,000.00 | 23,000,000.00 |
| Other Current Liabilities | N/A | 508,000,000.00 | 540,000,000.00 | 490,000,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 8,106,000,000.00 | 7,269,000,000.00 | 8,390,000,000.00 |
| Profit Loss From Operating Activities | 662,000,000.00 | 711,000,000.00 | 682,000,000.00 |
| Finance Income | 44,000,000.00 | 24,000,000.00 | 71,000,000.00 |
| Finance Costs | 111,000,000.00 | 124,000,000.00 | 159,000,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -64,000,000.00 | 16,000,000.00 | 12,000,000.00 |
| Profit Loss Before Tax | 595,000,000.00 | 611,000,000.00 | 594,000,000.00 |
| Income Tax Expense Continuing Operations | 106,000,000.00 | 123,000,000.00 | 124,000,000.00 |
| Profit Loss From Continuing Operations | 457,000,000.00 | 830,000,000.00 | 475,000,000.00 |
| Profit Loss From Discontinued Operations | 51,000,000.00 | 850,000,000.00 | 1,240,000,000.00 |
| Profit (loss) | 508,000,000.00 | 1,680,000,000.00 | 1,715,000,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 2,000,000.00 | 4,000,000.00 | 15,000,000.00 |
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 508,000,000.00 | 1,680,000,000.00 | 1,715,000,000.00 |
| Cash and cash equivalents | 871,000,000.00 | 1,561,000,000.00 | 2,755,000,000.00 |
Please note that some sums might not add up.
NL0000009827
LEI724500SNT1MK246AHP04
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryLife Sciences Tools & Services
Sub-IndustryLife Sciences Tools & Services
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.